Weight.com
Presented by Michael D. Myers, M.D., Inc.

Cypress, California
Objective Medical Information on Obesity,
Weight Management, Eating Disorders, and Related Topics.
Serving the Web Since June, 1995

Appointments: (562) 493-2266
skip skip skip
Obesity
   Prevalence (home)
   Definition
   Causes
   Why Be Worried?
   Psycho-Social Factors
   Medical Complications
   Medical Treatments
      Disastrous Therapies
         "Phen/fen"
         Dexfenfluramine
         Diuretics/Thyroid/etc.
      Current Obesity Meds
      Comprehensive Treatment
      Surgical Options
      Future Options
   Gimmicks & Low Carbs
   FAQ's

Weight Management Programs
   For Patients
   For Injured Workers
   For Case Managers

Eating Disorders
   Compulsive Overeating
   Diagnostic Criteria
   Eating Behaviors & Moods

Resources
   Patient Education
   Obesity Education Programs (first airing June, 2004)
   Consulting & Med-legal Asst

Cigna Hall of Shame

Accessibility/Section 508

Office Location/Appts.
   Michael D. Myers, M.D.,Inc.
   10601 Walker Street, Suite 250
   Cypress, CA (U.S.) 90630
   Voice: (562) 493-2266

Page 1 of 7 | Next page

Phentermine combined with fenfluramine ("Phen/Fen Diet"): How well does this combination work? (written in 1995)


IMPORTANT NOTICE:

The information below was written before fenfluramine was withdrawn from the market because of its association with valvular heart disease. This information is provided to give some perspective on the use of this combination and what went wrong.


Most people have heard of combining phentermine with fenfluramine ("phen/fen diet") in an attempt to control weight. Michael Weintraub, et al in a series of studies (Long-term weight control Study I , II, III, IV, V, VI, & VII in Clin Pharmacol Ther; May 1992) studied these medications in individuals over a period of 210 weeks. Both medications are anorexics (appetite suppressants) that help diminish appetite by different mechanisms of action. Phentermine is a stimulant acting through noradrenergic and dopaminergic pathways resulting in decreased appetite and less frequent eating. Fenfluramine acts through serotonergic mechanisms resulting in a feeling of increased satiety. Phentermine may produce "mild" side effects such as nervousness, irritability, insomnia, agitation, dizziness, dry mouth, constipation, elevated blood pressure, and rapid or irregular heartbeats.

Fenfluramine may produce somewhat opposite effects with drowsiness, sedation, diarrhea, and depression. Both medications can lead to serious side effects, with fenfluramine being associated with primary pulmonary hypertension, a life-threatening complication. Furthermore, in July 1997, a new complication (valvular heart disease) was found to be associated with the use of "phen/fen". The thinking was that by combining these two medications, one could take advantage of their different pharmacologic actions and get, in essence, better effectiveness while (hopefully) minimizing the "mild" side effects. The results of the studies are summarized below.

Patient participation

Patients were 18 to 60 years of age and weighed between 130% and 180% of their ideal body weights according to the 1983 Metropolitan Life Insurance Tables. The patients were in good health, not taking any long-term medications, and did not have hypertension (high blood pressure), diabetes, or other chronic diseases.

Medication

Phentermine resin (15 mg) combined with Fenfluramine (60 mg).

Behavior therapy

Active and ongoing behavior therapy with professionals trained in behavior modification techniques was an integral part of the study.

Caloric restriction

All individuals received individualized dietary counseling by dieticians to help limit calorie consumption to between 1500-1800 kcal per day for men and between 1000-1200 kcal per day for women.

Exercise

The participants in the study were started on graded exercise programs to expend at least an extra 300 kcal three times per week over their usual daily activities.

Medical monitoring

All participants were seen by physicians at regular intervals during the study, with periodic laboratory and electrocardiographic monitoring.


Page 1 of 7 | Next page

image of runners
Disclaimer Statement

The above information is for general purposes only and should not be construed as definitive or binding medical advice. Because each person is medically different, individuals should consult their own personal physicians for specific information and/or treatment recommendations.